Botulinum Toxin Injections in Musculoskeletal Disorders

被引：11
作者：
Godoy, Ivan R. B. [1 ,2 ]
Donahue, Dean M. [2 ,3 ]
Torriani, Martin [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Div Musculoskeletal Imaging & Intervent, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA USA
[3] Massachusetts Gen Hosp, Dept Surg, Div Thorac Surg, Boston, MA 02114 USA
来源：
SEMINARS IN MUSCULOSKELETAL RADIOLOGY | 2016年 / 20卷 / 05期
关键词：
botulinum toxin; muscle injection; ultrasound; intervention; THORACIC OUTLET SYNDROME; RANDOMIZED CONTROLLED-TRIAL; PIRIFORMIS MUSCLE SYNDROME; RESISTANT CERVICAL DYSTONIA; CHRONIC PLANTAR FASCIITIS; PLACEBO-CONTROLLED TRIAL; LOW-BACK-PAIN; CEREBRAL-PALSY; DOUBLE-BLIND; A TOXIN;
D O I：
10.1055/s-0036-1594284
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Botulinurn toxin (BTX) is used for multiple clinical indications due to its ability to induce temporary chemodenervation and muscle paralysis. This property has supported its application in treating a variety of musculoskeletal conditions, especially those involving muscular hyperactivity and contractures such as cerebral palsy and dystonia. However, off-label use of BTX injection in other musculoskeletal disorders is gaining increased acceptance, such as in neurogenic thoracic outlet syndrome, epicondylitis, and shoulder pain after stroke. This review discusses the mechanism of action, best practices, and current indications of BTX injections in the musculoskeletal system. We also discuss the state of the science regarding BTX injections for musculoskeletal disorders and the available evidence supporting its use.
引用
收藏
页码：441 / 452
页数：12
相关论文
共 115 条
[1]   An MRI evaluation of changes in piriformis muscle morphology induced by botulinum toxin injections in the treatment of piriformis syndrome [J].
Al-Al-Shaikh, M. ;
Michel, F. ;
Parratte, B. ;
Kastler, B. ;
Vidal, C. ;
Aubry, S. .
DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2015, 96 (01) :37-43
[2]   Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative - A double-blind, randomized controlled trial [J].
Alam, M ;
Dover, JS ;
Arndt, KA .
ARCHIVES OF DERMATOLOGY, 2002, 138 (04) :510-514
[3]  
[Anonymous], 1994, THERAPY BOTULINUM TO
[4]   Botulinum toxin as a biological weapon - Medical and public health management [J].
Arnon, SS ;
Schechter, R ;
Inglesby, TV ;
Henderson, DA ;
Bartlett, JG ;
Ascher, MS ;
Eitzen, E ;
Fine, AD ;
Hauer, J ;
Layton, M ;
Lillibridge, S ;
Osterholm, MT ;
O'Toole, T ;
Parker, G ;
Perl, TM ;
Russell, PK ;
Swerdlow, DL ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (08) :1059-1070
[5]   Treatment of pain attributed to plantar fasciitis with botulinum toxin A: A short-term, randomized, placebo-controlled, double-blind study [J].
Babcock, MS ;
Foster, L ;
Pasquina, P ;
Jabbari, B .
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2005, 84 (09) :649-654
[6]   Botulinum toxin type B (Myobloc) [J].
Baumann, L ;
Black, L .
DERMATOLOGIC SURGERY, 2003, 29 (05) :496-500
[7]   The cosmetic uses of Botulinum toxin type A [J].
Benedetto, AV .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1999, 38 (09) :641-655
[8]  
BERGENUDD H, 1988, CLIN ORTHOP RELAT R, P234
[9]   Botulinum toxin type a injections for the management of muscle tightness following total hip arthroplasty: A case series [J].
Bhave A. ;
Zywiel M.G. ;
Ulrich S.D. ;
McGrath M.S. ;
Seyler T.M. ;
Marker D.R. ;
Delanois R.E. ;
Mont M.A. .
Journal of Orthopaedic Surgery and Research, 4 (1)
[10]  
BINDER AI, 1983, BRIT J RHEUMATOL, V22, P73
12345678910